Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma › Research Explorer

Novosibirsk State University's Research Portal

Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma

Research output: Contribution to journal › Article › peer-review

DOI

https://doi.org/10.1134/S0026893321020060
Final published version

N. S. Dyrkheeva
A. L. Zakharenko
E. S. Novoselova
A. A. Chepanova
N. A. Popova
V. P. Nikolin
O. A. Luzina
N. F. Salakhutdinov
E. I. Ryabchikova
O. I. Lavrik

Original language	English
Pages (from-to)	273-277
Number of pages	5
Journal	Molecular Biology
Volume	55
Issue number	2
DOIs	https://doi.org/10.1134/S0026893321020060
Publication status	Published - Mar 2021

Research areas

Krebs-2 carcinoma, Tdp1 inhibitor, topoisomerase 1, topotecan, tyrosyl-DNA phosphodiesterase 1

OECD FOS+WOS

1.06 BIOLOGICAL SCIENCES

ID: 28496189